Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Runhai Medical Investment is a Chinese healthcare investment and management firm primarily focused on the development and operation of medical institutions and clinical service facilities. As a subsidiary of the Yunnan Baiyao Group, the company serves as a strategic vehicle for expanding the group's presence in the healthcare services sector, particularly through hospital management and medical technology investment. One of its flagship initiatives is the development of the Yunnan Baiyao International Medical Center, which aims to integrate traditional Chinese medicine with advanced modern clinical practices. The company's operations encompass medical equipment procurement, healthcare infrastructure investment, and the provision of specialized medical services within the Yunnan province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Runhai Medical Investment.